BG101847A - Human dnase i variants - Google Patents
Human dnase i variantsInfo
- Publication number
- BG101847A BG101847A BG101847A BG10184797A BG101847A BG 101847 A BG101847 A BG 101847A BG 101847 A BG101847 A BG 101847A BG 10184797 A BG10184797 A BG 10184797A BG 101847 A BG101847 A BG 101847A
- Authority
- BG
- Bulgaria
- Prior art keywords
- human dnase
- variants
- actin
- relates
- resistant variants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
The present invention relates to amino acid sequence variantsof human DNase I that have reduced binding affinity for actin. Theinvention provides nucleic acid sequences encoding suchactin-resistant variants, thereby enabling the production of thesevariants in quantities sufficient for clinical use. The inventionalso relates to pharmaceutical compositions and therapeutic usesof actin-resistant variants of human DNase I.22 claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/002366 WO1996026278A1 (en) | 1995-02-24 | 1995-02-24 | HUMAN DNase I VARIANTS |
US54052795A | 1995-10-10 | 1995-10-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
BG101847A true BG101847A (en) | 1998-07-31 |
BG64423B1 BG64423B1 (en) | 2005-01-31 |
Family
ID=24155835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG101847A BG64423B1 (en) | 1995-02-24 | 1997-08-21 | Human desoxyribonuclease i variants |
Country Status (5)
Country | Link |
---|---|
JP (3) | JP4624380B2 (en) |
BG (1) | BG64423B1 (en) |
CZ (1) | CZ297463B6 (en) |
MX (1) | MX9706429A (en) |
PT (1) | PT854927E (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3162372B2 (en) * | 1988-12-23 | 2001-04-25 | ジェネンテク,インコーポレイテッド | Human DNase |
US5464817A (en) * | 1990-04-11 | 1995-11-07 | Brigham And Women's Hospital | Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I |
-
1996
- 1996-02-21 MX MX9706429A patent/MX9706429A/en not_active IP Right Cessation
- 1996-02-21 CZ CZ0267897A patent/CZ297463B6/en not_active IP Right Cessation
- 1996-02-21 PT PT96907094T patent/PT854927E/en unknown
-
1997
- 1997-08-21 BG BG101847A patent/BG64423B1/en unknown
-
2007
- 2007-07-11 JP JP2007182662A patent/JP4624380B2/en not_active Expired - Lifetime
-
2009
- 2009-12-16 JP JP2009285728A patent/JP2010057516A/en active Pending
- 2009-12-16 JP JP2009285727A patent/JP2010088452A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CZ267897A3 (en) | 1998-01-14 |
BG64423B1 (en) | 2005-01-31 |
JP4624380B2 (en) | 2011-02-02 |
CZ297463B6 (en) | 2006-12-13 |
JP2010088452A (en) | 2010-04-22 |
JP2010057516A (en) | 2010-03-18 |
PT854927E (en) | 2008-09-08 |
JP2007312781A (en) | 2007-12-06 |
MX9706429A (en) | 1997-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT910647E (en) | Human dnase i hyperactive variants | |
WO1996034953A3 (en) | Cd16-ii variants | |
IL141021A (en) | Use of a polypeptide related to copolymer 1 for preparing a medicament for treating autoimmune diseases | |
DE69911401D1 (en) | Immunoregulator | |
EP1071443A4 (en) | Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof | |
DE69736276D1 (en) | HUMAN DNASE RESISTANT AGAINST ACTININHIBITORS | |
HUT77029A (en) | Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof | |
BG101846A (en) | HUMAN DNase I VARIANTS | |
TR199700842T1 (en) | �nsan DNase I Varyantlar�. | |
ATE312179T1 (en) | AGENT CONTAINING SERINE-THREONINE KINASE FOR TUMOR THERAPY AND TUMOR DIAGNOSIS | |
BG101847A (en) | Human dnase i variants | |
DE69730967D1 (en) | Human dnase ii | |
CA2242562A1 (en) | Human dnase resistant to actin inhibition | |
GB2329896A (en) | Enzyme and DNA sequence encoding same | |
YU182791A (en) | Tnf-muteini |